Approach to prevention and management of chronic lung allograft dysfunction in North American lung transplant centers
Authors:
- Siddhartha G. KapnadakSKSiddhartha G. Kapnadak
- Tijana MilinicTMTijana Milinic
- Eric D. MorrellEMEric D. Morrell
- William BrandonWBWilliam Brandon
- Megan MayerMMMegan Mayer
- Lianne G. SingerLSLianne G. Singer
- Albert FaroAFAlbert Faro
- Joseph M. PilewskiJPJoseph M. Pilewski
- Christopher H. GossCGChristopher H. Goss
- Nicole Mayer-HamblettNMNicole Mayer-Hamblett
- Ramsey HachemRHRamsey Hachem
- 8 June 2026
- journal article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 45 (9) , 1470-1473
Abstract
No abstract availableKeywords
Funding Information
- Cystic Fibrosis Foundation
- Foundation for the National Institutes of Health
- National Institutes of Health
This publication has 5 references indexed in Scilit:
- Chronic lung allograft dysfunction after lung transplantation: prevention, diagnosis and treatment in 44 European centresERJ Open Research, 2025
- Monitoring practices of chronic lung allograft dysfunction in pediatric lung transplantationPediatric Pulmonology, 2022
- Variability in azithromycin practices among lung transplant providers in the International Society for Heart and Lung Transplantation CommunityThe Journal of Heart and Lung Transplantation, 2021
- Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment―A consensus report from the Pulmonary Council of the ISHLTThe Journal of Heart and Lung Transplantation, 2019
- An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndromeEuropean Respiratory Journal, 2014